Profound Gastric Acid Inhibition: Advantages and Potential Hazards
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 24 (sup171), 99-105
- https://doi.org/10.3109/00365528909091379
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Effect of Omeprazole and Ranitidine on Ulcer Healing and Relapse Rates in Patients with Benign Gastric UlcerNew England Journal of Medicine, 1989
- Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.Gut, 1988
- Therapy with Omeprazole in Patients With Peptic Ulcerations Resistant to Extended High-Dose Ranitidine TreatmentDigestion, 1988
- Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.Gut, 1987
- Omeprazole in peptic ulcers resistant to histamine H2‐receptor antagonistsAlimentary Pharmacology & Therapeutics, 1987
- DOUBLE-BLIND MULTICENTRE COMPARISON OF OMEPRAZOLE AND RANITIDINE IN THE TREATMENT OF REFLUX OESOPHAGITISThe Lancet, 1987
- A Comparison of Two Different Doses of Omeprazole Versus Ranitidine in Treatment of Duodenal UlcersJournal of Clinical Gastroenterology, 1986
- Clinical Perspectives of Drugs Inhibiting Acid Secretion-H+K+-ATPase InhibitorsScandinavian Journal of Gastroenterology, 1986
- Effect of Omeprazole and Cimetidine on Duodenal UlcerNew England Journal of Medicine, 1985
- RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL ULCER RELAPSE *1A Double-blind, Randomised, Multicentre, Comparative TrialThe Lancet, 1984